Veerhealth Care Limited , a prominent player in the healthcare sector, has announced a significant boost to its export business with a new order from a US-based customer. The company has secured an order worth Rs 0.45 crore for its oral care products, marking a notable step in expanding its presence in the US market.

Order Details

The order, which involves the manufacture and supply of oral care products, specifically includes:

• 2 x 40 FT FCL (Full Container Load) containers
• Drug OTC (Over-The-Counter) range products
• Execution timeline of 30 days

Strategic Importance

This new order is expected to play a major role in Veerhealth Care's export business in the US market. The company views this as an opportunity to strengthen its foothold in the international arena, particularly in the competitive US healthcare sector.

Customer Confidentiality

Due to the terms of a Non-Disclosure Agreement (NDA), the identity of the US customer remains undisclosed. This practice is common in international business dealings, especially when dealing with sensitive market information or proprietary product details.

Corporate Governance

In compliance with SEBI regulations, Veerhealth Care has provided additional details about the order:

• The order was awarded by an international entity
• It does not involve any related party transactions
• There is no interest from the promoter or promoter group companies in the entity that awarded the order

Management's Perspective

Bhavin S. Shah, Managing Director of Veerhealth Care Limited, signed off on the regulatory filing, underlining the company's commitment to transparency and adherence to disclosure norms.

This development underscores Veerhealth Care's efforts to expand its international presence and boost its export business. The successful execution of this order within the stipulated timeframe could pave the way for more opportunities in the US market, potentially leading to sustained growth in the company's export segment.

Veerhealth Care has announced a significant business development, securing a new order worth Rs 0.49 crores for the manufacturing and supply of hair care products. The order comes from one of India's leading pharmacy chains, boasting over 5,000 retail outlets across the country.

Order Details

The company disclosed the following key details about the order:

• Order Value: Rs 0.49 crores
• Product Category: Hair Care Products
• Execution Timeline: 45 days
• Client: One of India's leading pharmacy chains (name undisclosed due to confidentiality)
• Client's Network: Over 5,000 retail pharmacy outlets, representing the largest retail pharmacy network in India

Business Impact

Veerhealth Care Limited anticipates that this order will contribute to additional growth in the company's turnover. The order's execution within a 45-day timeframe underscores the company's production capabilities and the client's confidence in Veerhealth's ability to deliver quality products promptly.

Corporate Governance

In compliance with SEBI regulations, Veerhealth Care Limited has confirmed that:

• The transaction does not involve any related party dealings.
• The company's promoters have no interest in the entity that awarded the contract.
• The order is from a domestic entity and is for the domestic market.

Management Statement

Bhavin S. Shah, Managing Director of Veerhealth Care Limited, stated, "This new order represents a significant opportunity for the Company, and we anticipate additional growth in turnover."

Company Overview

Veerhealth Care Limited, with its registered office in Mumbai, is engaged in the manufacturing of healthcare products. The company's production facility is located at Plot No. 224, Vibrant Business Park, Opp UPL, National Highway No. 8, Vapi - 396191, Gujarat.

This new order highlights Veerhealth Care Limited's growing presence in the hair care segment and its ability to secure contracts with major players in the Indian retail pharmacy sector. The successful execution of this order could potentially lead to more opportunities and strengthen the company's position in the healthcare products market.